Triple Negative Breast Cancer
Conditions
Brief summary
iDFS is defined as the time from the date of randomization to death from any cause or one of the following events (whichever occurs first): invasive local, regional, or distant recurrence, or invasive contralateral breast cancer.
Detailed description
OS is defined as the time from the date of randomization until death due to any cause., dDFS is defined as the time from the date of randomization to death from any cause or one of the following events (whichever occurs first): distant recurrence, or second primary invasive cancer., RFS is defined as the time from the date of randomization to death from any cause or one of the following events (whichever occurs first): invasive local, regional, or distant recurrence, Incidence of TEAEs and clinical laboratory abnormalities, TTW of QoL based on FACT-B Trial Outcome Index (TOI) score
Interventions
Sponsors
Eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| iDFS is defined as the time from the date of randomization to death from any cause or one of the following events (whichever occurs first): invasive local, regional, or distant recurrence, or invasive contralateral breast cancer. | — |
Secondary
| Measure | Time frame |
|---|---|
| OS is defined as the time from the date of randomization until death due to any cause., dDFS is defined as the time from the date of randomization to death from any cause or one of the following events (whichever occurs first): distant recurrence, or second primary invasive cancer., RFS is defined as the time from the date of randomization to death from any cause or one of the following events (whichever occurs first): invasive local, regional, or distant recurrence, Incidence of TEAEs and clinical laboratory abnormalities, TTW of QoL based on FACT-B Trial Outcome Index (TOI) score | — |
Countries
Belgium, France, Germany, Ireland, Italy, Spain